When Cryoport Inc (CYRX) went public in March, 2005, it was trading at US$ 50.80 per share. It was based on the promise that Cryoport would become the market leader in frozen shipping logistics solution to the biotechnology and life science industries. Back then, Cyroport’s solution were disruptive to the established technologies in the frozen shipping segment.

Shipments of biological materials had been frozen in dry ice, which often required re-icing during transit.… Read more